Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 88751-88800 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05320588
A Study in Patients With Advanced Cancers
PHASE1/PHASE2
Recruiting
332 participants
Started: Mar 25, 2022 · Completed: Apr 30, 2027
4 conditions
1 sponsor
3 locations
NCT04771650
A Hybrid Effectiveness Implementation Study of Latino/a Alcohol and Drug Users
NA
Active, not recruiting
220 participants
Started: Mar 25, 2022 · Completed: Aug 1, 2028
3 conditions
4 sponsors
2 locations
NCT04769895
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
PHASE3
Active, not recruiting
66 participants
Started: Mar 25, 2022 · Completed: Nov 30, 2025
2 conditions
1 sponsor
50 locations
NCT04332588
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
PHASE1
Recruiting
25 participants
Started: Mar 25, 2022 · Completed: Aug 31, 2027
1 condition
1 sponsor
1 location
NCT05375045
Real-life Evaluation of the Safety and Performance of EUROTEKNIKA Dental Implants
N/A
Recruiting
868 participants
Started: Mar 25, 2022 · Completed: Feb 1, 2028
1 condition
2 sponsors
1 location
NCT05269628
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
PHASE2
Recruiting
166 participants
Started: Mar 25, 2022 · Completed: Aug 30, 2027
3 conditions
2 sponsors
1 location
NCT05104502
Immunomodulatory Effects of Fasting in Healthy Adults
NA
Recruiting
4 participants
Started: Mar 25, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05539248
A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNH
PHASE1/PHASE2
Recruiting
78 participants
Started: Mar 25, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04928846
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
PHASE3
Recruiting
698 participants
Started: Mar 25, 2022 · Completed: Mar 31, 2028
1 condition
1 sponsor
307 locations
NCT06103812
Evaluate Performance and Safety of Hyalo4 Skin in Acute and Chronic Wounds
N/A
Recruiting
170 participants
Started: Mar 24, 2022 · Completed: Jan 31, 2024
1 condition
1 sponsor
6 locations
NCT05345860
Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer
NA
Recruiting
300 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2027
1 condition
3 sponsors
3 locations
NCT05233787
Trial Evaluating the Tailored Versus the Systematic Use of Defunctioning Stoma After Total Mesorectal Excision for Rectal Cancer (GRECCAR17)
NA
Recruiting
212 participants
Started: Mar 24, 2022 · Completed: Sep 30, 2025
2 conditions
1 sponsor
28 locations
NCT05224141
Pembrolizumab/Vibostolimab (MK-7684A) or Atezolizumab in Combination With Chemotherapy in First Line Treatment of Extensive-Stage Small Cell Lung Cancer (MK-7684A-008/KEYVIBE-008)
PHASE3
Active, not recruiting
460 participants
Started: Mar 24, 2022 · Completed: Jun 7, 2027
1 condition
1 sponsor
140 locations
NCT05095649
Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib
PHASE2
Recruiting
15 participants
Started: Mar 24, 2022 · Completed: Feb 15, 2026
1 condition
1 sponsor
1 location
NCT05226598
Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007)
PHASE3
Active, not recruiting
739 participants
Started: Mar 24, 2022 · Completed: Jan 9, 2026
1 condition
1 sponsor
149 locations
NCT05477576
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
PHASE3
Recruiting
288 participants
Started: Mar 24, 2022 · Completed: Jul 31, 2028
7 conditions
1 sponsor
53 locations
NCT06273501
MRI and Magnetometer-guided Sentinel Lymph Node Detection in Vulvar Cancer
NA
Enrolling by invitation
20 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05286229
A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in Japan
PHASE1
Active, not recruiting
8 participants
Started: Mar 24, 2022 · Completed: Mar 31, 2026
1 condition
1 sponsor
6 locations
NCT04162938
Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
NA
Recruiting
308 participants
Started: Mar 24, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT05297708
Office, Home, and Ambulatory Blood Pressure
N/A
Active, not recruiting
52 participants
Started: Mar 24, 2022 · Completed: Sep 1, 2026
1 condition
1 sponsor
1 location
NCT05285761
feediNg gUidelines infanT RandomIzEd coNtrolled Trial
NA
Recruiting
330 participants
Started: Mar 24, 2022 · Completed: Mar 31, 2027
1 condition
5 sponsors
1 location
NCT05307939
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
PHASE2
Recruiting
30 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2026
5 conditions
1 sponsor
7 locations
NCT04825990
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
PHASE2
Recruiting
30 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2028
1 condition
1 sponsor
1 location
NCT04484441
Maternal-fetal Immune Responses to Fetal Surgery
N/A
Active, not recruiting
60 participants
Started: Mar 24, 2022 · Completed: Dec 30, 2025
4 conditions
1 sponsor
3 locations
NCT07103694
i-NEED: NEw migrainE Drugs Database
N/A
Recruiting
2,641 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05213572
Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies
N/A
Recruiting
200 participants
Started: Mar 24, 2022 · Completed: Jun 1, 2035
5 conditions
1 sponsor
1 location
NCT06250465
AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
N/A
Recruiting
500 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
9 locations
NCT05569161
To Evaluate the Safety and Clinical Radiological Outcomes in 2 Years of Embrance Model Reverse Shoulder Arthroplasty
N/A
Recruiting
250 participants
Started: Mar 24, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT05269862
Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation
NA
Active, not recruiting
100 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
18 locations
NCT05135559
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
PHASE3
Active, not recruiting
153 participants
Started: Mar 24, 2022 · Completed: Nov 2, 2029
1 condition
1 sponsor
77 locations
NCT05010590
Anabolic Therapy in Postmenopausal Osteoporosis
PHASE4
Active, not recruiting
50 participants
Started: Mar 24, 2022 · Completed: Nov 1, 2027
1 condition
1 sponsor
1 location
NCT05323383
The Effects and Mechanisms of Brief Mindfulness Meditation and Hypnosis for Pain
NA
Recruiting
300 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT05287477
Passive Evaluation in Operational Environment of the AI Clinician Decision Support System for Sepsis Treatment
N/A
Recruiting
15 participants
Started: Mar 24, 2022 · Completed: Aug 31, 2024
1 condition
2 sponsors
2 locations
NCT06535451
Lung Cancer Screening Program in Mexico
N/A
Recruiting
1,000 participants
Started: Mar 24, 2022 · Completed: Mar 24, 2027
1 condition
1 sponsor
1 location
NCT05452057
Prehab for Adult Spinal Deformity Surgery
NA
Active, not recruiting
24 participants
Started: Mar 24, 2022 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT05216770
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
EARLY_PHASE1
Recruiting
165 participants
Started: Mar 24, 2022 · Completed: Aug 31, 2026
3 conditions
2 sponsors
1 location
NCT06144385
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
PHASE1
Recruiting
20 participants
Started: Mar 24, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05237245
Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)
N/A
Recruiting
120 participants
Started: Mar 23, 2022 · Completed: Mar 31, 2027
3 conditions
1 sponsor
1 location
NCT05184803
A Phase 2 Study of Neoadjuvant Docetaxel, Oxaliplatin, S-1 in Patients With Unresectable Locally Advanced or Distant Metastasis Limited to Lymph Node Gastric Cancer
PHASE2
Recruiting
63 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05866380
Early Identification of Heart Failure in a High-Risk Diabetic Cohort
N/A
Active, not recruiting
3,500 participants
Started: Mar 23, 2022 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT05241418
Atrial Late Gadolinium Enhancement in Patients with Repaired Congenital Heart Disease
N/A
Recruiting
50 participants
Started: Mar 23, 2022 · Completed: Jun 30, 2029
3 conditions
1 sponsor
1 location
NCT05316324
A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction
PHASE3
Active, not recruiting
353 participants
Started: Mar 23, 2022 · Completed: Mar 31, 2026
1 condition
2 sponsors
2 locations
NCT06501469
Biomarkers in Parkinsonian Syndromes
N/A
Recruiting
200 participants
Started: Mar 23, 2022 · Completed: Mar 25, 2030
5 conditions
2 sponsors
1 location
NCT05226117
Sacituzumab Govitecan, Preceding Radical Cystectomy, in Treating Patients With Muscle-invasive Bladder Cancer
PHASE2
Recruiting
44 participants
Started: Mar 23, 2022 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT04713605
Cerebral Blood Flow in Neonates During Major Cardiac Surgery.
N/A
Recruiting
80 participants
Started: Mar 23, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05525338
Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels
PHASE4
Recruiting
196 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2026
5 conditions
7 sponsors
8 locations
NCT05227664
A Study of AK117/AK112 in Metastatic Triple-Negative Breast Cancer
PHASE2
Recruiting
120 participants
Started: Mar 23, 2022 · Completed: Dec 30, 2026
2 conditions
1 sponsor
2 locations
NCT05346757
Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening, Surveillance and Diagnosis
NA
Recruiting
5,390 participants
Started: Mar 23, 2022 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT05275478
Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
PHASE1/PHASE2
Active, not recruiting
192 participants
Started: Mar 23, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
20 locations
NCT05297500
Determination of SpO2 and PR Accuracy Specifications At Rest (71Ag_Vital-0031)
N/A
Active, not recruiting
12 participants
Started: Mar 23, 2022 · Completed: Mar 29, 2025
1 condition
2 sponsors
1 location
Previous
1
More pages
1773
1774
1775
1776
1777
1778
1779
More pages
2369
Next